Azelastine, a common nasal spray for allergies, reduced the risk of COVID-19 and colds in one small trial. Larger studies are ...

Researchers say people using a common allergy nasal spray, azelastine, were 69% less likely to contract COVID-19.

“Azelastine nasal spray could provide an additional easily accessible prophylactic to complement existing protective measures, especially for vulnerable groups, during periods of high infection rates, ...

In the intention-to-treat population, the incidence of polymerase chain reaction-confirmed SARS-CoV-2 infection was significantly lower in the azelastine group vs the placebo group. HealthDay News — ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Azelastine lowered the risk for SARS-CoV-2 infection vs.

An everyday hay fever spray may do more than tame sneezes. In a rigorously run German trial, adults who used azelastine nasal spray three times a day were less likely to catch COVID-19 than those who ...

WASHINGTON (TNND) — A nasal spray might help healthy adults combat COVID-19, according to a study out of Germany. The news comes as coronavirus cases recently popped up again in the U.S. The study ...

Researchers discuss the effects of azelastine nasal spray on the rate of SARS-CoV-2 infection as compared to placebo.

FRIDAY, Sept. 5, 2025 (HealthDay News) -- Azelastine nasal spray is associated with a reduced risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, according to a study ...

A nasal spray might help healthy adults combat COVID-19, according to a study out of Germany. The news comes as coronavirus cases have recently started increasing again in the United States. As of Aug ...